A new implant treatment for, Benign Prostatic Hyperplasia (BPH), the UroLift System, is available for men 50 years or older. Having an enlarged prostate can result in restricted urine flow.
This can later lead to bladder damage and other issues.
The UroLift System opens up the prostate by holding back the lobes of the enlarged prostate, similar to how curtains and pulled back.
A 19-inch needle is inserted into the body by the UroLift Delivery Device. Designed with an eight millimeter stainless steel urethral end piece, a nitinol capsular tab, and a PET suture, the implant “hugs” the prostate, squeezing it together in an effort to minimize it.
This opens up the path for urine flow.
This procedure was recently completed for the first time at Winthrop-University Hospital by Jeffery Schiff, MD, FACS, Attending Urologist.
“This is a major advancement in treating BPH, and we encourage men with an enlarged prostate to explore this revolutionary, minimally-invasive procedure as a way to provide relief from chronic symptoms that interfere with their daily lives,” says Dr. Schiff.
“Winthrop-University Hospital is committed to providing patients with the highest quality, most effective options to address their health and urology needs. The UroLift System has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients.”
This device was cleared by the U.S. Food and Drug Administration (FDA) in 2013.
